Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» When it comes to PCSK9s, payers resisted — and sales flopped
When it comes to PCSK9s, payers resisted — and sales flopped
When it comes to PCSK9s, payers resisted — and sales flopped
Submitted by
admin
on January 11, 2017 - 9:54am
Source:
Medical Marketing and Media
News Tags:
PCSK9 inhibitors
payers
Amgen
Sanofi
Regeneron
Repatha
Praluent
Headline:
When it comes to PCSK9s, payers resisted — and sales flopped
Do Not Allow Advertisers to Use My Personal information
